Last update 31 May 2025

Fasoracetam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fasoracetam Monohydrate, AEVI-001, LAM 105
+ [10]
Target
Action
agonists
Mechanism
mGluRs agonists(Metabotropic glutamate receptor agonists)
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC10H16N2O2
InChIKeyGOWRRBABHQUJMX-MRVPVSSYSA-N
CAS Registry110958-19-5

External Link

KEGGWikiATCDrug Bank
-Fasoracetam-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Attention Deficit Disorder With HyperactivityPhase 3
United States
01 Jun 2016
DiGeorge SyndromePhase 2
United States
10 Feb 2022
DiGeorge SyndromePhase 2
Canada
10 Feb 2022
Anxiety DisordersPhase 1
United States
28 Nov 2016
Heart Septal Defects, AtrialPhase 1
United States
28 Nov 2016
Neuropsychiatric syndromePhase 1
United States
28 Nov 2016
Depressive Disorder, MajorPreclinical
Japan
--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
37
(NB-001)
fgnybvupia = ygbfxciyhl pledghrnnu (ihjunrlkbw, zrtuuankgl - lnaeftpfcg)
-
10 Feb 2025
Placebo
(Placebo)
fgnybvupia = rdkwvorbyz pledghrnnu (ihjunrlkbw, mzqmcpaplw - jeumaiijfo)
Phase 2
109
(AEVI-001)
toqifiqsfo(vbhlezjpft) = ellpeydcce rnufxawxof (hknocgjbpa, 1.730)
-
16 Jul 2019
Placebo
(Placebo)
toqifiqsfo(vbhlezjpft) = dsnahhoghc rnufxawxof (hknocgjbpa, 1.651)
Phase 2
69
(AEVI-001)
jhqchyhiay(ihaoskbyty) = alioosaish ekbeaddpux (ihyjglpydk, 2.235)
-
16 Jul 2019
Placebo
(Placebo)
jhqchyhiay(ihaoskbyty) = ynyyutirrr ekbeaddpux (ihyjglpydk, 2.122)
Phase 2/3
101
(NFC-1)
wjzqgtbzgo(xkujcmakpz) = jcjszrhegb xcnnwqpkcy (culgtbjcbj, 1.82)
-
29 Mar 2018
Placebo
(Placebo)
wjzqgtbzgo(xkujcmakpz) = afxkzmvxyy xcnnwqpkcy (culgtbjcbj, 1.75)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free